NUVB
NUVB
NYSE · Pharmaceuticals

Nuvation Bio Inc

$4.49
+0.04 (+0.90%)
As of May 9, 1:30 AM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target +862.6% upside
Low Target $30.63
Average Target $43.22
High Target $69.64
Current Price $4.49
Current
$4.49
Target
$43.22
$30.63 $43.22 avg $69.64
Scenario Analysis
Bear Case
$30.63
582.2%
Low target
Base Case
$43.22
+862.6%
Avg target
Bull Case
$69.64
+1,451.0%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$9.75
-53.9% from high
52-Week Low
$1.57
+186.0% from low
Target vs 52W High
$43.22
+343.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%